CD4 and neoplasm: However, it is worth noting that tumor-derived mRNA allows the transfection of TAAs and co-stimulatory molecules, ensuring antigen presentation in MHC-I without requiring cross-presentation, but it cannot induce a potent CD4+ immune response (120).